AwesomeCapital
Search This Blog
Wednesday, November 4, 2020
Regenxbio EPS beats by $1.14, beats on revenue
Regenxbio
(NASDAQ:
RGNX
)
: Q3 GAAP EPS of $0.24
beats by $1.14
.
Revenue of $98.9M (+572.8% Y/Y)
beats by $74.1M
.
Shares
+1.5%
.
Press Release
https://seekingalpha.com/news/3631476-regenxbio-eps-beats-1_14-beats-on-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.